U.S. Building Stock News

Sarepta Therapeutics (NasdaqGS:SRPT) received Medsafe approval in New Zealand for its first-in-human clinical trial of SRP-1005. SRP-1005 is an investigational siRNA therapeutic targeting Huntington's Disease, a severe neurodegenerative condition. The authorization allows Sarepta to begin a Phase 1 study, marking its clinical entry into Huntington's Disease research. Sarepta Therapeutics is best known for its Duchenne muscular dystrophy franchise, and SRP-1005 broadens its rare disease...

Core Natural Resources (CNR) has posted a mixed set of FY 2025 numbers, with Q3 revenue at about US$1.0 billion and basic EPS of US$0.61 alongside a trailing twelve month loss of US$43.4 million on basic EPS of US$0.94. The company has seen quarterly revenue move from US$553.4 million in Q3 2024 to more than US$1.0 billion in Q3 2025, while basic EPS has swung between a profit of US$3.23 and a loss of US$1.38 over that stretch. This highlights how volatile margins have been. For investors,...

If you are wondering whether Easterly Government Properties is fairly priced or offering value right now, this article will walk you through what the numbers actually say. The stock last closed at US$23.79, with a 30 day return of 6.3% and an 11.6% return year to date, set against a 3.1% decline over the past year and a 23.7% and 37.1% decline over the past 3 and 5 years respectively. Recent coverage of Easterly Government Properties has focused on its position as a real estate investment...

In February 2026, American International Group reported full-year 2025 results showing revenue of US$26.78 billion, net income of US$3.10 billion versus a prior-year net loss, declared a US$0.45 quarterly dividend, and confirmed completion of a long-running buyback program totaling about US$59.79 billion. Management also highlighted stronger underwriting income in the General Insurance segment, higher adjusted earnings, and new minority stakes in Convex Group and Onex Corporation that are...

Veralto (VLTO) is back in focus after fourth quarter revenue came in slightly below Wall Street expectations. Management pointed to fewer shipping days and softer industrial and municipal demand as key factors. See our latest analysis for Veralto. Those earnings and M&A comments landed against a weaker tape, with the latest share price at $91.98 and a 30 day share price return of 9.62% decline, adding to a 1 year total shareholder return of 7.37% decline. This suggests momentum has cooled as...

Kadant stock: event driven snapshot Kadant (KAI) has been drawing investor attention after recent share price moves, with the stock closing at $333.55. That puts the company’s market performance front and center for anyone tracking capital goods names. See our latest analysis for Kadant. That recent pullback of 0.39% on the day sits against a stronger backdrop, with a 30 day share price return of 7.03% and a 90 day gain of 30.85%. This comes even as the 1 year total shareholder return shows a...

Wendy's launched two new limited time items nationwide: the Cheesy Bacon Cheeseburger and Chicken Tenders Ranch Wrap. The releases are part of the company's Project Fresh turnaround plan, which focuses on menu changes and operations. The move comes as Wendy's closes hundreds of stores and faces pressure from declining sales. For investors watching NasdaqGS:WEN, this product push lands at a challenging point. The stock last closed at $7.27 and has seen a 47.8% decline over the past year and...

What is moving Amphastar Pharmaceuticals now? Amphastar Pharmaceuticals (AMPH) has drawn investor attention after its recent share performance, with the stock around $27.55 and short term returns mixed between the past week, month and past 3 months. See our latest analysis for Amphastar Pharmaceuticals. At around $27.55, Amphastar Pharmaceuticals has given investors a mixed ride, with recent share price returns over the past week and month soft, while the 90 day share price return of 5.72%...

If you are wondering whether ACM Research's share price still lines up with its fundamentals, this article walks through what the current valuation metrics are actually telling you. The stock last closed at US$64.10, with returns of 17.9% over 7 days, 24.9% over 30 days, 42.8% year to date, 176.3% over 1 year and 391.2% over 3 years, which naturally raises questions about how the recent price compares with estimated fair value. Recent news around ACM Research has focused on its role in...

If you are wondering whether Tencent Music Entertainment Group's current share price reflects its true worth, you are not alone. This article is built to help you make sense of the numbers. The stock closed at US$15.15, with returns of a 4.9% decline over the last 7 days, a 13.8% decline over 30 days, a 15.2% decline year to date, a 20.2% gain over 1 year, an 87.1% gain over 3 years, and a 42.3% decline over 5 years. Recent moves therefore sit within a mixed longer term picture. Recent...

The trigger for TransMedics Group (TMDX) stock today is the U.S. FDA granting full IDE approval for its Next Generation OCS ENHANCE Heart trial, a key step for advanced heart transplant procedures. See our latest analysis for TransMedics Group. Despite today’s reaction, with the share price at $128.52 after a 1-day share price return of a 3.59% decline and a softer 30-day share price return of a 9.94% decline, momentum over the past quarter remains positive and the 1-year total shareholder...

GlobalFoundries Inc. has reported its fourth-quarter and full-year 2025 results, showing flat quarterly sales of US$1,830 million year-on-year but a move from a net loss to net income, alongside new guidance for first-quarter 2026 revenue of about US$1,625 million and diluted EPS around US$0.23. The company is pairing this return to profitability with a US$500 million share repurchase program, acquisitions in silicon photonics and processor IP, and leadership changes, as it aims to deepen...

If you are wondering whether Kodiak AI at around US$8.35 is starting to look interesting on price alone, it helps to step back and look at what the current market is implying about its value. Over the short term, the stock has been under pressure, with a 7 day return of 4.4% decline, a 30 day return of 11.1% decline, and a year to date return of 22.9% decline, contributing to a 24.4% decline over the past year. This weaker share price backdrop is unfolding alongside broader evergreen...

In early February 2026, PotlatchDeltic Corporation was removed from the NASDAQ Composite Index, while multiple long-running ESOP-related shelf registrations for common stock were formally closed. This combination highlights how a technical index change, rather than routine employee stock plan administration, can have an outsized influence on trading flows and investor attention. Next, we’ll examine how PotlatchDeltic’s removal from the NASDAQ Composite Index could affect its existing...

Simon Property Group (SPG) has drawn fresh attention after unveiling a transformational plan for the former Neiman Marcus space at Boston's Copley Place, introducing new luxury retailers and high profile dining concepts. See our latest analysis for Simon Property Group. Recent news has arrived alongside mixed share price moves, with Simon Property Group's 1 day share price return of a 1.71% decline and 7 day share price return of a 2.96% decline contrasting with a 30 day share price return of...

FirstEnergy (NYSE:FE) announced a 4.5% increase to its quarterly dividend. The company also provided forward dividend guidance, outlining expectations for higher annual payouts. Management linked the dividend update to confidence in the company’s ongoing transformation and operations. For income focused investors watching utilities, this dividend move from FirstEnergy comes on top of a solid share price run. NYSE:FE is trading at $48.84, with the stock up 3.9% over the past week and 7.8%...

If you are wondering whether Tower Semiconductor is still priced reasonably after its strong run, or if you might be looking at a stretched stock, this article walks through what the current share price could mean for you. The stock last closed at US$133.58, with returns of 3.5% over 7 days, 7.1% over 30 days, 9.7% year to date, 177.1% over 1 year and 321.5% over 5 years. This naturally raises questions about what is already baked into the price. Recent news flow around Tower Semiconductor...

If you are wondering whether Wynn Resorts at around US$107.85 is offering fair value or a potential mismatch between price and worth, you are not alone. That question is exactly what this article will unpack for you. The stock is down 4.7% over the last week and 7.3% over the last month, while still showing a 35.3% return over the past year and 2.3% over three years. It has a 7.4% decline across five years and a 12.0% decline year to date. Recent attention on Wynn Resorts has focused on how...

In early February 2026, Atlassian reported second-quarter fiscal 2026 results showing revenue of US$1,586.32 million and a net loss of US$42.65 million, alongside completing a US$779.19 million share repurchase program and filing a US$1.41 billion shelf registration for an ESOP-related Class A share offering. The combination of strong top-line growth, raised full-year revenue guidance, and simultaneous capital actions, both buybacks and potential new share issuance, highlights how management...

Earnings, guidance and buybacks set the tone for Cirrus Logic (CRUS) Cirrus Logic (CRUS) has just combined a fresh earnings release, new quarterly revenue guidance and an update on its ongoing share repurchases, giving investors several new data points to assess the stock. See our latest analysis for Cirrus Logic. The recent earnings, fresh quarterly revenue guidance and active buyback program come against a backdrop of firm positive momentum, with a 30 day share price return of 14.96% and a...

If you are wondering whether Johnson Controls International is priced attractively right now, you are not alone. This article will walk through what the current share price could mean for investors focused on value. The stock last closed at US$138.57, with returns of 4.6% over 7 days, 23.6% over 30 days, 13.3% year to date, 58.9% over 1 year, 128.6% over 3 years and 175.8% over 5 years. This raises fair questions about how much of the story is already reflected in the price. Recent attention...

Cummins (CMI) is back in focus after its latest quarterly earnings update, a mixed market reaction to GAAP results, fresh 2026 guidance, a higher dividend, and sharper priorities for its Accelera business. See our latest analysis for Cummins. The recent earnings volatility, updated 2026 guidance and higher dividend have all landed against a strong run in the shares. Cummins’ 90 day share price return of 27.28% and 1 year total shareholder return of 62.62% point to momentum that has been...

The Chefs' Warehouse, Inc. recently reported its fourth-quarter and full-year 2025 results, with sales rising to US$1.14 billion for the quarter and US$4.15 billion for the year, alongside higher annual net income and earnings per share from continuing operations versus 2024. Management also highlighted ongoing share buybacks and a strong pipeline of potential acquisitions, emphasizing disciplined, low‑risk “fold‑in” deals that could enhance territories and complement the company’s existing...

Event driven overview of Parsons stock Parsons (PSN) shares have recently moved against mixed short term returns, with a 4.0% gain over the past day but a decline over the past week, month, and past 3 months catching investor attention. See our latest analysis for Parsons. The latest 4.0% 1 day share price gain to $62.67 comes after a 9.4% 30 day share price decline and a 14.6% 1 year total shareholder return decline. This means recent momentum looks softer, even though the 3 and 5 year total...